Philippe Lory, Ph.D. - Publications

Affiliations: 
Département de Physiologie CNRS, Montpellier, Montpellier, Occitanie, France 
Area:
ion channels
Website:
http://www.igf.cnrs.fr/

100 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Chemin J, Stamenic TT, Cazade M, Llinares J, Blesneac I, Todorovic SM, Lory P. A novel phospho-modulatory mechanism contributes to the calcium-dependent regulation of T-type Ca channels. Scientific Reports. 9: 15642. PMID 31666636 DOI: 10.1038/s41598-019-52194-6  0.52
2019 Bouasse M, Impheng H, Servant Z, Lory P, Monteil A. Functional expression of CLIFAHDD and IHPRF pathogenic variants of the NALCN channel in neuronal cells reveals both gain- and loss-of-function properties. Scientific Reports. 9: 11791. PMID 31409833 DOI: 10.1038/s41598-019-48071-x  0.52
2018 Chemin J, Siquier-Pernet K, Nicouleau M, Barcia G, Ahmad A, Medina-Cano D, Hanein S, Altin N, Hubert L, Bole-Feysot C, Fourage C, Nitschké P, Thevenon J, Rio M, Blanc P, ... ... Lory P, et al. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene. Brain : a Journal of Neurology. PMID 29878067 DOI: 10.1093/brain/awy145  0.52
2017 El Alaoui C, Chemin J, Fechtali T, Lory P. Modulation of T-type Ca2+ channels by Lavender and Rosemary extracts. Plos One. 12: e0186864. PMID 29073181 DOI: 10.1371/journal.pone.0186864  0.52
2017 Dorgans K, Salvi J, Bertaso F, Bernard L, Lory P, Doussau F, Mezghrani A. Characterization of the dominant inheritance mechanism of Episodic Ataxia type 2. Neurobiology of Disease. PMID 28688851 DOI: 10.1016/j.nbd.2017.07.004  0.4
2017 Cazade M, Bidaud I, Lory P, Chemin J. Activity-dependent regulation of T-type calcium channels by submembrane calcium ions. Elife. 6. PMID 28109159 DOI: 10.7554/eLife.22331  0.68
2016 Daniil G, Fernandes-Rosa FL, Chemin J, Blesneac I, Beltrand J, Polak M, Jeunemaitre X, Boulkroun S, Amar L, Strom TM, Lory P, Zennaro MC. CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism. Ebiomedicine. PMID 27729216 DOI: 10.1016/j.ebiom.2016.10.002  0.52
2015 Gangarossa G, Sakkaki S, Lory P, Valjent E. Mouse hippocampal phosphorylation footprint induced by generalized seizures: Focus on ERK, mTORC1 and Akt/GSK-3 pathways. Neuroscience. 311: 474-483. PMID 26545981 DOI: 10.1016/j.neuroscience.2015.10.051  1
2015 Blesneac I, Chemin J, Bidaud I, Huc-Brandt S, Vandermoere F, Lory P. Phosphorylation of the Cav3.2 T-type calcium channel directly regulates its gating properties. Proceedings of the National Academy of Sciences of the United States of America. 112: 13705-10. PMID 26483470 DOI: 10.1073/pnas.1511740112  1
2015 Sakkaki S, Gangarossa G, Lerat B, Françon D, Forichon L, Chemin J, Valjent E, Lerner-Natoli M, Lory P. Blockade of T-type calcium channels prevents tonic-clonic seizures in a maximal electroshock seizure model. Neuropharmacology. 101: 320-329. PMID 26456350 DOI: 10.1016/j.neuropharm.2015.09.032  1
2015 Coutelier M, Blesneac I, Monteil A, Monin ML, Ando K, Mundwiller E, Brusco A, Le Ber I, Anheim M, Castrioto A, Duyckaerts C, Brice A, Durr A, Lory P, Stevanin G. A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia. American Journal of Human Genetics. 97: 726-37. PMID 26456284 DOI: 10.1016/j.ajhg.2015.09.007  1
2015 Monteil A, Chausson P, Boutourlinsky K, Mezghrani A, Huc-Brandt S, Blesneac I, Bidaud I, Lemmers C, Leresche N, Lambert RC, Lory P. Inhibition of Cav3.2 T-type Calcium Channels by Its Intracellular I-II Loop. The Journal of Biological Chemistry. 290: 16168-76. PMID 25931121 DOI: 10.1074/jbc.M114.634261  1
2015 Chong JX, McMillin MJ, Shively KM, Beck AE, Marvin CT, Armenteros JR, Buckingham KJ, Nkinsi NT, Boyle EA, Berry MN, Bocian M, Foulds N, Uzielli ML, Haldeman-Englert C, Hennekam RC, ... ... Lory P, et al. De novo mutations in NALCN cause a syndrome characterized by congenital contractures of the limbs and face, hypotonia, and developmental delay. American Journal of Human Genetics. 96: 462-73. PMID 25683120 DOI: 10.1016/j.ajhg.2015.01.003  1
2014 Cochet-Bissuel M, Lory P, Monteil A. The sodium leak channel, NALCN, in health and disease. Frontiers in Cellular Neuroscience. 8: 132. PMID 24904279 DOI: 10.3389/fncel.2014.00132  1
2014 Salvi J, Bertaso F, Mausset-Bonnefont AL, Metz A, Lemmers C, Ango F, Fagni L, Lory P, Mezghrani A. RNAi silencing of P/Q-type calcium channels in Purkinje neurons of adult mouse leads to episodic ataxia type 2. Neurobiology of Disease. 68: 47-56. PMID 24768804 DOI: 10.1016/j.nbd.2014.04.005  1
2014 Chemin J, Cazade M, Lory P. Modulation of T-type calcium channels by bioactive lipids. PflüGers Archiv : European Journal of Physiology. 466: 689-700. PMID 24531745 DOI: 10.1007/s00424-014-1467-5  1
2014 Cazade M, Bidaud I, Hansen PB, Lory P, Chemin J. 5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone. PflüGers Archiv : European Journal of Physiology. 466: 1759-68. PMID 24327205 DOI: 10.1007/s00424-013-1411-0  1
2014 Cazade M, Nuss CE, Bidaud I, Renger JJ, Uebele VN, Lory P, Chemin J. Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2. Molecular Pharmacology. 85: 218-25. PMID 24214826 DOI: 10.1124/mol.113.089581  1
2013 Björling K, Morita H, Olsen MF, Prodan A, Hansen PB, Lory P, Holstein-Rathlou NH, Jensen LJ. Myogenic tone is impaired at low arterial pressure in mice deficient in the low-voltage-activated CaV 3.1 T-type Ca(2+) channel. Acta Physiologica (Oxford, England). 207: 709-20. PMID 23356724 DOI: 10.1111/apha.12066  1
2012 Chevalier M, Gilbert G, Lory P, Marthan R, Quignard JF, Savineau JP. Dehydroepiandrosterone (DHEA) inhibits voltage-gated T-type calcium channels. Biochemical Pharmacology. 83: 1530-9. PMID 22391268 DOI: 10.1016/j.bcp.2012.02.025  1
2012 Weiss N, Hameed S, Fernández-Fernández JM, Fablet K, Karmazinova M, Poillot C, Proft J, Chen L, Bidaud I, Monteil A, Huc-Brandt S, Lacinova L, Lory P, Zamponi GW, De Waard M. A Ca(v)3.2/syntaxin-1A signaling complex controls T-type channel activity and low-threshold exocytosis. The Journal of Biological Chemistry. 287: 2810-8. PMID 22130660 DOI: 10.1074/jbc.M111.290882  1
2011 Bidaud I, Lory P. Hallmarks of the channelopathies associated with L-type calcium channels: a focus on the Timothy mutations in Ca(v)1.2 channels. Biochimie. 93: 2080-6. PMID 21664226 DOI: 10.1016/j.biochi.2011.05.015  1
2010 Swayne LA, Mezghrani A, Lory P, Nargeot J, Monteil A. The NALCN ion channel is a new actor in pancreatic β-cell physiology. Islets. 2: 54-6. PMID 21099296 DOI: 10.4161/isl.2.1.10522  1
2010 Lory P, Mezghrani A. Calcium channelopathies in inherited neurological disorders: relevance to drug screening for acquired channel disorders. Idrugs : the Investigational Drugs Journal. 13: 467-71. PMID 20582871  1
2010 Zamponi GW, Lory P, Perez-Reyes E. Role of voltage-gated calcium channels in epilepsy. PflüGers Archiv : European Journal of Physiology. 460: 395-403. PMID 20091047 DOI: 10.1007/s00424-009-0772-x  1
2010 Bidaud I, Nargeot J, Lory P. A new mechanism regulating plasma membrane expression of Cav3.2 T-type calcium channels: Implication in childhood absence epilepsy | Identification d'un mécanisme régulant l'expression membranaire des canaux calciques de type T (Cav3.2): Implications dans l'épilepsie-absences de l'enfant Epilepsies. 22: 51-61. DOI: 10.1684/epi.2010.0285  1
2009 Barbara G, Alloui A, Nargeot J, Lory P, Eschalier A, Bourinet E, Chemin J. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 13106-14. PMID 19846698 DOI: 10.1523/JNEUROSCI.2919-09.2009  1
2009 Swayne LA, Mezghrani A, Varrault A, Chemin J, Bertrand G, Dalle S, Bourinet E, Lory P, Miller RJ, Nargeot J, Monteil A. The NALCN ion channel is activated by M3 muscarinic receptors in a pancreatic beta-cell line. Embo Reports. 10: 873-80. PMID 19575010 DOI: 10.1038/embor.2009.125  1
2009 Huc S, Monteil A, Bidaud I, Barbara G, Chemin J, Lory P. Regulation of T-type calcium channels: signalling pathways and functional implications. Biochimica Et Biophysica Acta. 1793: 947-52. PMID 19071165 DOI: 10.1016/j.bbamcr.2008.11.003  1
2008 Shcheglovitov A, Vitko I, Bidaud I, Baumgart JP, Navarro-Gonzalez MF, Grayson TH, Lory P, Hill CE, Perez-Reyes E. Alternative splicing within the I-II loop controls surface expression of T-type Ca(v)3.1 calcium channels. Febs Letters. 582: 3765-70. PMID 18930057 DOI: 10.1016/j.febslet.2008.10.013  0.6
2008 Shuba YM, Perez-Reyes E, Lory P, Noebels J. T-type calcium channels: from discovery to channelopathies, 25 years of research. Channels (Austin, Tex.). 2: 299-302. PMID 18769138 DOI: 10.4161/chan.2.4.6577  1
2008 Baumgart JP, Vitko I, Bidaud I, Kondratskyi A, Lory P, Perez-Reyes E. I-II loop structural determinants in the gating and surface expression of low voltage-activated calcium channels. Plos One. 3: e2976. PMID 18714336 DOI: 10.1371/journal.pone.0002976  1
2008 Mezghrani A, Monteil A, Watschinger K, Sinnegger-Brauns MJ, Barrère C, Bourinet E, Nargeot J, Striessnig J, Lory P. A destructive interaction mechanism accounts for dominant-negative effects of misfolded mutants of voltage-gated calcium channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 4501-11. PMID 18434528 DOI: 10.1523/JNEUROSCI.2844-07.2008  1
2007 Chemin J, Mezghrani A, Bidaud I, Dupasquier S, Marger F, Barrère C, Nargeot J, Lory P. Temperature-dependent modulation of CaV3 T-type calcium channels by protein kinases C and A in mammalian cells. The Journal of Biological Chemistry. 282: 32710-8. PMID 17855364 DOI: 10.1074/jbc.M702746200  1
2007 Lory P, Chemin J. Towards the discovery of novel T-type calcium channel blockers. Expert Opinion On Therapeutic Targets. 11: 717-22. PMID 17465728 DOI: 10.1517/14728222.11.5.717  1
2007 Singh B, Monteil A, Bidaud I, Sugimoto Y, Suzuki T, Hamano S, Oguni H, Osawa M, Alonso ME, Delgado-Escueta AV, Inoue Y, Yasui-Furukori N, Kaneko S, Lory P, Yamakawa K. Mutational analysis of CACNA1G in idiopathic generalized epilepsy. Mutation in brief #962. Online. Human Mutation. 28: 524-5. PMID 17397049 DOI: 10.1002/humu.9491  1
2007 Vitko I, Bidaud I, Arias JM, Mezghrani A, Lory P, Perez-Reyes E. The I-II loop controls plasma membrane expression and gating of Ca(v)3.2 T-type Ca2+ channels: a paradigm for childhood absence epilepsy mutations. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 322-30. PMID 17215393 DOI: 10.1523/JNEUROSCI.1817-06.2007  1
2007 Chemin J, Nargeot J, Lory P. Chemical determinants involved in anandamide-induced inhibition of T-type calcium channels. The Journal of Biological Chemistry. 282: 2314-23. PMID 17121818 DOI: 10.1074/jbc.M610033200  1
2007 Traboulsie A, Chemin J, Chevalier M, Quignard JF, Nargeot J, Lory P. Subunit-specific modulation of T-type calcium channels by zinc. The Journal of Physiology. 578: 159-71. PMID 17082234 DOI: 10.1113/jphysiol.2006.114496  1
2006 Perez-Reyes E, Lory P. Molecular biology of T-type calcium channels. Cns & Neurological Disorders Drug Targets. 5: 605-9. PMID 17168745 DOI: 10.2174/187152706779025508  1
2006 Lory P, Bidaud I, Mezghrani A, Monteil A. [Calcium channelopathies: the current challenges]. MéDecine Sciences : M/S. 22: 1028-31. PMID 17156720 DOI: 10.1051/medsci/200622121028  1
2006 Bidaud I, Mezghrani A, Swayne LA, Monteil A, Lory P. Voltage-gated calcium channels in genetic diseases. Biochimica Et Biophysica Acta. 1763: 1169-74. PMID 17034879 DOI: 10.1016/j.bbamcr.2006.08.049  1
2006 DePuy SD, Yao J, Hu C, McIntire W, Bidaud I, Lory P, Rastinejad F, Gonzalez C, Garrison JC, Barrett PQ. The molecular basis for T-type Ca2+ channel inhibition by G protein beta2gamma2 subunits. Proceedings of the National Academy of Sciences of the United States of America. 103: 14590-5. PMID 16973746 DOI: 10.1073/pnas.0603945103  1
2006 Gavarini S, Bécamel C, Altier C, Lory P, Poncet J, Wijnholds J, Bockaert J, Marin P. Opposite effects of PSD-95 and MPP3 PDZ proteins on serotonin 5-hydroxytryptamine2C receptor desensitization and membrane stability. Molecular Biology of the Cell. 17: 4619-31. PMID 16914526 DOI: 10.1091/mbc.E06-03-0218  1
2006 Chemin J, Traboulsie A, Lory P. Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones. Cell Calcium. 40: 121-34. PMID 16797700 DOI: 10.1016/j.ceca.2006.04.015  1
2006 Lory P, Bidaud I, Chemin J. T-type calcium channels in differentiation and proliferation. Cell Calcium. 40: 135-46. PMID 16797068 DOI: 10.1016/j.ceca.2006.04.017  1
2006 Chevalier M, Lory P, Mironneau C, Macrez N, Quignard JF. T-type CaV3.3 calcium channels produce spontaneous low-threshold action potentials and intracellular calcium oscillations. The European Journal of Neuroscience. 23: 2321-9. PMID 16706840 DOI: 10.1111/j.1460-9568.2006.04761.x  1
2006 Mangoni ME, Traboulsie A, Leoni AL, Couette B, Marger L, Le Quang K, Kupfer E, Cohen-Solal A, Vilar J, Shin HS, Escande D, Charpentier F, Nargeot J, Lory P. Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels. Circulation Research. 98: 1422-30. PMID 16690884 DOI: 10.1161/01.RES.0000225862.14314.49  1
2006 Bidaud I, Monteil A, Nargeot J, Lory P. Properties and role of voltage-dependent calcium channels during mouse skeletal muscle differentiation. Journal of Muscle Research and Cell Motility. 27: 75-81. PMID 16538437 DOI: 10.1007/s10974-006-9058-5  1
2006 Traboulsie A, Chemin J, Kupfer E, Nargeot J, Lory P. T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. Molecular Pharmacology. 69: 1963-8. PMID 16510561 DOI: 10.1124/mol.105.020842  1
2006 Gackière F, Bidaux G, Lory P, Prevarskaya N, Mariot P. A role for voltage gated T-type calcium channels in mediating "capacitative" calcium entry? Cell Calcium. 39: 357-66. PMID 16442617 DOI: 10.1016/j.ceca.2005.12.003  1
2005 Autret L, Mechaly I, Scamps F, Valmier J, Lory P, Desmadryl G. The involvement of Cav3.2/alpha1H T-type calcium channels in excitability of mouse embryonic primary vestibular neurones. The Journal of Physiology. 567: 67-78. PMID 15961427 DOI: 10.1113/jphysiol.2005.089342  1
2004 Gomes B, Savignac M, Moreau M, Leclerc C, Lory P, Guery JC, Pelletier L. Lymphocyte calcium signaling involves dihydropyridine-sensitive L-type calcium channels: facts and controversies. Critical Reviews in Immunology. 24: 425-47. PMID 15777162 DOI: 10.1615/CritRevImmunol.v24.i6.30  1
2004 Lory P, Nargeot J. [Genetic diversity of voltage-gated calcium channels]. Revue Neurologique. 160: S7-15. PMID 15269655  1
2004 Dubel SJ, Altier C, Chaumont S, Lory P, Bourinet E, Nargeot J. Plasma membrane expression of T-type calcium channel alpha(1) subunits is modulated by high voltage-activated auxiliary subunits. The Journal of Biological Chemistry. 279: 29263-9. PMID 15123697 DOI: 10.1074/jbc.M313450200  1
2004 Chemin J, Nargeot J, Lory P. Ca(v)3.2 calcium channels control an autocrine mechanism that promotes neuroblastoma cell differentiation. Neuroreport. 15: 671-5. PMID 15094473 DOI: 10.1097/00001756-200403220-00019  1
2003 Chemin J, Monteil A, Lory P. [Functional specificity of T-type calcium channels and their roles in neuronal differentiation]. Journal De La SociéTé De Biologie. 197: 235-47. PMID 14708345  1
2002 Bidaud I, Lory P, Nicolas P, Bulant M, Ladram A. Characterization and functional expression of cDNAs encoding thyrotropin-releasing hormone receptor from Xenopus laevis. European Journal of Biochemistry / Febs. 269: 4566-76. PMID 12230569 DOI: 10.1046/j.1432-1033.2002.03152.x  1
2002 Chemin J, Nargeot J, Lory P. Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6856-62. PMID 12177183  1
2002 Chemin J, Monteil A, Perez-Reyes E, Bourinet E, Nargeot J, Lory P. Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability. The Journal of Physiology. 540: 3-14. PMID 11927664 DOI: 10.1113/jphysiol.2001.013269  1
2002 Berthier C, Monteil A, Lory P, Strube C. Alpha(1H) mRNA in single skeletal muscle fibres accounts for T-type calcium current transient expression during fetal development in mice. The Journal of Physiology. 539: 681-91. PMID 11897840 DOI: 10.1113/jphysiol.2001.013246  1
2001 Chemin J, Monteil A, Dubel S, Nargeot J, Lory P. The alpha1I T-type calcium channel exhibits faster gating properties when overexpressed in neuroblastoma/glioma NG 108-15 cells. The European Journal of Neuroscience. 14: 1678-86. PMID 11860462 DOI: 10.1046/j.0953-816X.2001.01796.x  1
2001 Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. The Embo Journal. 20: 7033-40. PMID 11742980 DOI: 10.1093/emboj/20.24.7033  1
2001 Chemin J, Monteil A, Bourinet E, Nargeot J, Lory P. Alternatively spliced alpha(1G) (Ca(V)3.1) intracellular loops promote specific T-type Ca(2+) channel gating properties. Biophysical Journal. 80: 1238-50. PMID 11222288 DOI: 10.1016/S0006-3495(01)76100-0  1
2001 Quignard JF, Harricane MC, Ménard C, Lory P, Nargeot J, Capron L, Mornet D, Richard S. Transient down-regulation of L-type Ca(2+) channel and dystrophin expression after balloon injury in rat aortic cells. Cardiovascular Research. 49: 177-88. PMID 11121810 DOI: 10.1016/S0008-6363(00)00210-8  1
2001 Lory P, Monteil A, Chemin J, Bourinet E, Nargeot J. T-type calcium channels: From cloning to physiology | Du clonage des canaux calciques de type T à l'étude de leurs rôles physiologiques Medecine/Sciences. 17: 979-988.  1
2000 Lory P, Monteil A, Chemin J, Leuranguer V, Bourinet E, Nargeot J. [Molecular diversity of calcium channel activities by depolarization]. ThéRapie. 55: 249-54. PMID 10967696  1
2000 Chemin J, Monteil A, Briquaire C, Richard S, Perez-Reyes E, Nargeot J, Lory P. Overexpression of T-type calcium channels in HEK-293 cells increases intracellular calcium without affecting cellular proliferation. Febs Letters. 478: 166-72. PMID 10922490 DOI: 10.1016/S0014-5793(00)01832-9  1
2000 Monteil A, Chemin J, Leuranguer V, Altier C, Mennessier G, Bourinet E, Lory P, Nargeot J. Specific properties of T-type calcium channels generated by the human alpha 1I subunit. The Journal of Biological Chemistry. 275: 16530-5. PMID 10749850 DOI: 10.1074/jbc.C000090200  1
2000 Monteil A, Chemin J, Bourinet E, Mennessier G, Lory P, Nargeot J. Molecular and functional properties of the human alpha(1G) subunit that forms T-type calcium channels. The Journal of Biological Chemistry. 275: 6090-100. PMID 10692398 DOI: 10.1074/jbc.275.9.6090  1
1999 Ménard C, Pupier S, Mornet D, Kitzmann M, Nargeot J, Lory P. Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. The Journal of Biological Chemistry. 274: 29063-70. PMID 10506158 DOI: 10.1074/jbc.274.41.29063  1
1998 Lory P, Monteil A. [Physiopathology of calcium channels: identification of calcium channelopathies]. Comptes Rendus Des SéAnces De La SociéTé De Biologie Et De Ses Filiales. 192: 137-47. PMID 9759359  1
1998 Richard S, Lory P, Bourinet E, Nargeot J. Molecular physiology of human cardiovascular ion channels: from electrophysiology to molecular genetics. Methods in Enzymology. 293: 71-88. PMID 9711603 DOI: 10.1016/S0076-6879(98)93008-7  1
1998 Leuranguer V, Bourinet E, Lory P, Nargeot J. Antisense depletion of beta-subunits fails to affect T-type calcium channels properties in a neuroblastoma cell line. Neuropharmacology. 37: 701-8. PMID 9707283 DOI: 10.1016/S0028-3908(98)00060-4  1
1998 Chaloin L, Vidal P, Lory P, Méry J, Lautredou N, Divita G, Heitz F. Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties. Biochemical and Biophysical Research Communications. 243: 601-8. PMID 9480855 DOI: 10.1006/bbrc.1997.8050  1
1997 Pellegrin P, Menard C, Mery J, Lory P, Charnet P, Bennes R. Cell cycle dependent toxicity of an amphiphilic synthetic peptide. Febs Letters. 418: 101-5. PMID 9414104 DOI: 10.1016/S0014-5793(97)01339-2  1
1997 Lory P, Monteil A, Nargeot J. [Molecular genetics of cardiovascular calcium channels]. Archives Des Maladies Du Coeur Et Des Vaisseaux. 90: 17-24. PMID 9295919  1
1997 Taviaux S, Williams ME, Harpold MM, Nargeot J, Lory P. Assignment of human genes for beta 2 and beta 4 subunits of voltage-dependent Ca2+ channels to chromosomes 10p12 and 2q22-q23. Human Genetics. 100: 151-4. PMID 9254841 DOI: 10.1007/s004390050482  1
1997 Lory P, Ophoff RA, Nahmias J. Towards a unified nomenclature describing voltage-gated calcium channel genes. Human Genetics. 100: 149-50. PMID 9254840 DOI: 10.1007/s004390050481  1
1997 Lapie P, Lory P, Fontaine B. Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel. Neuromuscular Disorders : Nmd. 7: 234-40. PMID 9196905 DOI: 10.1016/S0960-8966(97)00435-5  1
1997 Nargeot J, Lory P, Richard S. Molecular basis of the diversity of calcium channels in cardiovascular tissues. European Heart Journal. 18: A15-26. PMID 9049536  1
1996 Lapie P, Goudet C, Nargeot J, Fontaine B, Lory P. Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle alpha 1s subunit as expressed in mouse L cells. Febs Letters. 382: 244-8. PMID 8605978 DOI: 10.1016/0014-5793(96)00173-1  1
1995 Charnet P, Lory P, Bourinet E, Collin T, Nargeot J. cAMP-dependent phosphorylation of the cardiac L-type Ca channel: a missing link? Biochimie. 77: 957-62. PMID 8834778 DOI: 10.1016/0300-9084(95)80008-5  1
1995 Diriong S, Lory P, Williams ME, Ellis SB, Harpold MM, Taviaux S. Chromosomal localization of the human genes for alpha 1A, alpha 1B, and alpha 1E voltage-dependent Ca2+ channel subunits. Genomics. 30: 605-9. PMID 8825650 DOI: 10.1006/geno.1995.1284  1
1995 Varadi G, Mikala G, Lory P, Varadi M, Drouet B, Pinçon-Raymond M, Schwartz A. Endogenous cardiac Ca2+ channels do not overcome the E-C coupling defect in immortalized dysgenic muscle cells: evidence for a missing link. Febs Letters. 368: 405-10. PMID 7635187 DOI: 10.1016/0014-5793(95)00697-8  1
1994 Collin T, Lory P, Taviaux S, Courtieu C, Guilbault P, Berta P, Nargeot J. Cloning, chromosomal location and functional expression of the human voltage-dependent calcium-channel beta 3 subunit. European Journal of Biochemistry / Febs. 220: 257-62. PMID 8119293  1
1993 Lory P, Varadi G, Slish DF, Varadi M, Schwartz A. Characterization of beta subunit modulation of a rabbit cardiac L-type Ca2+ channel alpha 1 subunit as expressed in mouse L cells. Febs Letters. 315: 167-72. PMID 8380271 DOI: 10.1016/0014-5793(93)81156-T  1
1993 Krizanova O, Diebold R, Lory P, Schwartz A. Molecular aspects and diversity of voltage-dependent calcium channels Circulation. 87: VII44-VII48.  1
1992 Lory P, Nargeot J. Cyclic AMP-dependent modulation of cardiac Ca channels expressed in Xenopus laevis oocytes. Biochemical and Biophysical Research Communications. 182: 1059-65. PMID 1371671 DOI: 10.1016/0006-291X(92)91839-I  1
1992 Bourinet E, Fournier F, Lory P, Charnet P, Nargeot J. Protein kinase C regulation of cardiac calcium channels expressed in Xenopus oocytes. PflüGers Archiv : European Journal of Physiology. 421: 247-55. PMID 1326746 DOI: 10.1007/BF00374834  1
1992 Lory P, Varadi G, Schwartz A. The beta subunit controls the gating and dihydropyridine sensitivity of the skeletal muscle Ca2+ channel. Biophysical Journal. 63: 1421-4. PMID 1282375 DOI: 10.1016/S0006-3495(92)81705-8  1
1991 Varadi G, Lory P, Schultz D, Varadi M, Schwartz A. Acceleration of activation and inactivation by the beta subunit of the skeletal muscle calcium channel. Nature. 352: 159-62. PMID 1712427 DOI: 10.1038/352159a0  1
1990 Rassendren FA, Lory P, Pin JP, Nargeot J. Zinc has opposite effects on NMDA and non-NMDA receptors expressed in Xenopus oocytes. Neuron. 4: 733-40. PMID 2160837 DOI: 10.1016/0896-6273(90)90199-P  1
1990 Van Obberghen-Schilling E, Chambard JC, Lory P, Nargeot J, Pouysségur J. Functional expression of Ca2(+)-mobilizing alpha-thrombin receptors in mRNA-injected Xenopus oocytes. Febs Letters. 262: 330-4. PMID 2159419 DOI: 10.1016/0014-5793(90)80221-4  1
1990 Picard A, Cavadore JC, Lory P, Bernengo JC, Ojeda C, Dorée M. Microinjection of a conserved peptide sequence of p34cdc2 induces a Ca2+ transient in oocytes. Science (New York, N.Y.). 247: 327-9. PMID 2153316  1
1990 Fournier F, Jdaïâa H, Lory P, Brûlé G, Curgy JJ, Guilbault P. Expression of calcium channels in Xenopus oocyte injected with crab skeletal muscle fibre mRNA. Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 68: 37-42. PMID 1969298 DOI: 10.1016/0248-4900(90)90284-A  1
1990 Tiaho F, Richard S, Lory P, Nerbonne JM, Nargeot J. Cyclic-AMP-dependent phosphorylation modulates the stereospecific activation of cardiac Ca channels by Bay K 8644. PflüGers Archiv : European Journal of Physiology. 417: 58-66. PMID 1705699 DOI: 10.1007/BF00370769  1
1990 Lory P, Rassendren FA, Richard S, Tiaho F, Nargeot J. Characterization of voltage-dependent calcium channels expressed in Xenopus oocytes injected with mRNA from rat heart. The Journal of Physiology. 429: 95-112. PMID 1703576  1
1989 Lory P, Richard S, Rassendren FA, Tiaho F, Nargeot J. Electrophysiological expression of endothelin and angiotensin receptors in Xenopus oocytes injected with rat heart mRNA. Febs Letters. 258: 289-92. PMID 2480916 DOI: 10.1016/0014-5793(89)81676-X  1
1989 Rassendren FA, Lory P, Pin JP, Bockaert J, Nargeot J. A specific quisqualate agonist inhibits kainate responses induced in Xenopus oocytes injected with rat brain RNA. Neuroscience Letters. 99: 333-9. PMID 2471121 DOI: 10.1016/0304-3940(89)90469-2  1
Show low-probability matches.